Horace H. Loh

Horace H. Loh

Auto-generated profile, based on publicly available information

Horace H. Loh

Laboratory of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Ministry of Science and Technology, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2003 in Synapse
Verified
Journal Article
Open access
PDF file
JYJi‐Hoon Yoo
Ji‐Hoon Yoo
HYHan Young Yu
Han Young Yu
HLHorace H. Loh
Horace H. Loh
IHIng K. Ho
Ing K. Ho
CJChoon-Gon Jang
Choon-Gon Jang
Repeated administration of nicotine produces behavioral sensitization. However, the possible mechanism of behavioral sensitization to nicotine remains unclear. The present study was undertaken in μ‐opioid receptor knockout mice, to examine the hypothesis that μ‐opioid receptors play a crucial role in behavioral sensitization to nicotine. All mice received saline or nicotine (0.05 mg/kg, s.c) twice a day for 7 consecutive days. The mice remained drug free for 3 days and on day 11 each group was challenged with saline or nicotine (0.05 mg/kg, s.c.). On day 1, it was observed that the single injection of nicotine (0.05 mg/kg, s.c.) did not influence locomotor activity in either μ‐opioid receptor knockout or in wildtype mice. On day 7 (24 h after mice had been treated twice daily for 6 consecutive days with an injection of 0.05 mg/kg of nicotine), the mice were challenged with a single injection of nicotine, which produced behavioral sensitization in the wildtype but not in μ‐opioid receptor knockout mice. On day 11, following 3 days of withdrawal after the second injection of nicotine on day 7, nicotine‐treated mice were challenged with a single injection of nicotine and showed the behavioral sensitization of wildtype. However, nicotine challenge did not induce behavioral sensitization in μ‐opioid receptor knockout mice. Our data indicate that a lack of μ‐opioid receptors can inhibit the effects of nicotine‐induced behavioral sensitization. This result strongly suggests that the μ‐opioid receptor plays an important role in behavioral sensitization to nicotine. Synapse 51:219–223, 2004.


8 June 2021 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
XLXiaonan Li
Xiaonan Li
TYTao Yu
Tao Yu
YAyixiang ai
yixiang ai
XWXueyuan Wang
Xueyuan Wang
JYJiaqing Yan
Jiaqing Yan
XYXiaofeng Yang
Xiaofeng Yang
Accurate localization of the epileptogenic zone (EZ) is a key factor to obtain good surgical outcome for refractory epilepsy patients. However, no technique, so far, can precisely locate the EZ, and there are barely any reports on the combined application of multiple technologies to improve the localization accuracy of the EZ. In this study, we aimed to explore the use of a multimodal method combining PET-MRI, fluid and white matter suppression (FLAWS)—a novel MRI sequence, and high-frequency oscillation (HFO) automated analysis to delineate EZ. We retrospectively collected 15 patients with refractory epilepsy who underwent surgery and used the above three methods to detect abnormal brain areas of all patients. We compared the PET-MRI, FLAWS, and HFO results with traditional methods to evaluate their diagnostic value. The sensitivities, specificities of locating the EZ, and marking extent removed versus not removed [RatioChann(ev)] of each method were compared with surgical outcome. We also tested the possibility of using different combinations to locate the EZ. The marked areas in every patient established using each method were also compared to determine the correlations among the three methods. The results showed that PET-MRI, FLAWS, and HFOs can provide more information about potential epileptic areas than traditional methods. When detecting the EZs, the sensitivities of PET-MRI, FLAWS, and HFOs were 68.75, 53.85, and 87.50%, and the specificities were 80.00, 33.33, and 100.00%. The RatioChann(ev) of HFO-marked contacts was significantly higher in patients with good outcome than those with poor outcome (p< 0.05). When intracranial electrodes covered all the abnormal areas indicated by neuroimaging with the overlapping EZs being completely removed referred to HFO analysis, patients could reach seizure-free (p < 0.01). The periphery of the lesion marked by neuroimaging may be epileptic, but not every lesion contributes to seizures. Therefore, approaches in multimodality can detect EZ more accurately, and HFO analysis may help in defining real epileptic areas that may be missed in the neuroimaging results. The implantation of intracranial electrodes guided by non-invasive PET-MRI and FLAWS findings as well as HFO analysis would be an optimized multimodal approach for locating EZ.

28 February 2001 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BBBertrand Le Bourdonnec
Bertrand Le Bourdonnec
RKRachid El Kouhen
Rachid El Kouhen
GPGennady Poda
Gennady Poda
PLPing Y. Law
Ping Y. Law
HLHorace H. Loh
Horace H. Loh
PPPhilip S. Portoghese
Philip S. Portoghese

28 September 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
FMFei Meng
Fei Meng
YLYuan Li
Yuan Li
HSHao Sun
Hao Sun
CLChangpeng Li
Changpeng Li
QLQian Li
Qian Li
HZHui Zheng
Hui Zheng

16 April 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
YHYihan Huang
Yihan Huang
SYShiu-Hwa Yeh
Shiu-Hwa Yeh
HLHorace H. Loh
Horace H. Loh
JCJian-Yin Chuang
Jian-Yin Chuang
Full‐length 7‐transmembrane (TM) variants of mu opioid receptor (MOR) share similar amino acid sequences of TM domains in rodents and humans; however, interspecies differences in N‐ and C‐terminal amino acid sequences of MOR splice variants dramatically affect the downstream signaling. Thus, it is essential to develop a mouse model that expresses human MOR for opioid pharmacological studies. We generated two lines of fully humanized MOR mice, line #1 and #2. The novel murine model having human OPRM1 genes and human‐specific variants was examined by RT‐PCR. Humanized MOR mice were characterized in vivo using a tail‐flick, charcoal meal, open field, tail suspension, naloxone precipitation tests, and rectal temperature measurement. The data indicated that wild‐type (WT) and humanized MOR mice exhibited different pharmacology of morphine, including antinociception, tolerance, sedation, and withdrawal syndromes, suggesting the presence of species difference between mouse and human MORs. Therefore, humanized MOR mice could serve as a novel mouse model for pharmacogenetic studies of opioids.